Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)
Completed · Phase 2 · NCT04484142
Conditions: Non-small Cell Lung Cancer
At a glance
- Research payments reported, 2025
- $490,628
- U.S. investigators named
- 10
- Sites paid
- 9
- Planned or actual enrollment
- 137
About the trial
- Sponsor
- Daiichi Sankyo (with AstraZeneca)
- Tested
- DS-1062a (drug)
- Dates
- Started 2021-03-30; completion 2026-02-04
- Results posted
- Yes
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung cancer (NSCLC) with known actionable genomic alterations.
From ClinicalTrials.gov, last updated 2026-03-24. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Daiichi Sankyo Inc. reported $490,628 in research payments for this study in 2025 (47 payments).
Products named: Datroway
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Aaron Lisberg, MD Hematology & Oncology · Santa Monica, CA
- Michael R. Shafique, MD Medical Oncology · Tampa, FL
- Rebecca S. Heist, MD MPH Internal Medicine · Boston, MA
- Jacob M. Sands, MD Hematology & Oncology · Burlington, MA
- Frederick P. Smith, M.D. Medical Oncology · Chevy Chase, MD
- Shirish M. Gadgeel, MD Medical Oncology · Detroit, MI
- Saiama N. Waqar, MD Medical Oncology · Saint Louis, MO
- Barbara T. Ma, MD Hematology & Oncology · New York, NY
- Elaine Shum, M.D. Hematology & Oncology · New York, NY
- George R. Blumenschein JR., M.D. Medical Oncology · Houston, TX
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Ronald Reagan UCLA Medical Center, CA $232,044
- Ut MD Anderson Cancer Center $106,010
- Dana-Farber Cancer Institute $104,002
- Moffitt Cancer Center $12,351
- NYU School of Medicine $10,700
- $6,559
- Weill Medical College of Cornell University $6,278
- The Washington University $5,516
- The Office of Frederick P Smith MD $5,100
- Henry Ford Health Hospital, MI $2,067
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.